Advances in the field of tissue engineering and regenerative medicine: State of the art and regulatory issues

Journal of Biomaterials and Tissue Engineering

Volumn 3, Issue 3, 2013, Pages 245-260

  Gonzalez Andrades, M ^a   Garzon I ^a   Alaminos, M ^a   Campos, A ^a   Prosper, F ^b   Orive, G ^c,d,e   Anitua, E ^e  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^e Biotechnology Institute BTI   (Spain)

Author keywords

Extracellular matrix; Growth factors; Morphogens; Stem cells; Tissue engineering

Indexed keywords

ALUMINUM OXIDE; BIOMATERIAL; CELLULOSE; CHITOSAN; EPIDERMAL GROWTH FACTOR; FIBRIN; FIBROBLAST GROWTH FACTOR 2; HYALURONIC ACID; MATRIGEL; PLATELET DERIVED GROWTH FACTOR; POLYCAPROLACTONE; POLYGLACTIN; POLYLACTIC ACID; SCATTER FACTOR; SOMATOMEDIN; TISSUE SCAFFOLD; TITANIUM DIOXIDE; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADULT STEM CELL; BIOCOMPATIBILITY; BONE DISEASE; CARDIOVASCULAR DISEASE; CARTILAGE INJURY; CELL DIFFERENTIATION; CELL GROWTH; DEGENERATIVE DISEASE; EXTRACELLULAR MATRIX; HUMAN; MESENCHYMAL STEM CELL; POLYMERIZATION; REGENERATIVE MEDICINE; REVIEW; SOMATIC CELL THERAPY; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REGENERATION;

EID: 84891620073     PISSN: 21579083     EISSN: 21579091     Source Type: Journal    
DOI: 10.1166/jbt.2013.1089     Document Type: Review

References (93)

1. R. Langer and J. P. Vacanti, Tissue engineering. Science 260, 920 (1993).
2. J. R. Wolter and R. F. Meyer, Sessile macrophages forming clear endothelium-like membrane on inside of successful keratoprosthesis. Trans. Am. Ophthalmol. Soc. 82, 187 (1984).
3. S. J. Hollister and W. L. Murphy, Scaffold translation: Barriers between concept and clinic. Tissue Eng. Part B Rev. 17, 459 (2011).
4. N. Cuende and A. Izeta, Clinical translation of stem cell therapies: A bridgeable gap. Cell Stem Cell 6, 508 (2010).
5. R. P. Pillow, R. B. Epstein, C. D. Buckner, E. R. Giblett, and E. D. Thomas, Treatment of bone-marrow failure by isogeneic marrow infusion. N. Engl. J. Med. 275, 94 (1966).
6. O. Bergmann, R. D. Bhardwaj, S. Bernard, S. Zdunek, F. Barnabe-Heider, S. Walsh, J. Zupicich, K. Alkass, B. A. Buchholz, H. Druid, S. Jovinge, and J. Frisen, Evidence for cardiomyocyte renewal in humans. Science 324, 98 (2009).
7. N. Sanai, A. D. Tramontin, A. Quinones-Hinojosa, N. M. Barbaro, N. Gupta, S. Kunwar, M. T. Lawton, M. W. McDermott, A. T. Parsa, J. Manuel-Garcia Verdugo, M. S. Berger, and A. Alvarez-Buylla, Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature 427, 740 (2004).
8. V. F. Segers and R. T. Lee, Stem-cell therapy for cardiac disease. Nature 451, 937 (2008).
9. N. Joyce, G. Annett, L. Wirthlin, S. Olson, G. Bauer, and J. A. Nolta, Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen. Med. 5, 933 (2010).
10. C. M. Coleman, C. Curtin, F. P. Barry, C. O'Flatharta, and J. M. Murphy, Mesenchymal stem cells and osteoarthritis: Remedy or accomplice? Hum. Gene. Ther. 21, 1239 (2010).
11. A. Trounson, R. G. Thakar, G. Lomax, and D. Gibbons, Clinical trials for stem cell therapies. BMC Med. 9, 52 (2011).
12. L. Sensebe, M. Krampera, H. Schrezenmeier, P. Bourin, and R. Giordano, Mesenchymal stem cells for clinical application. Vox. Sang. 98, 93 (2010).
13. S. Janssens, Stem cells in the treatment of heart disease. Annu. Rev. Med. 61, 287 (2010).
14. D. Karussis, C. Karageorgiou, A. Vaknin-Dembinsky, B. Gowda-Kurkalli, J. M. Gomori, I. Kassis, J. W. Bulte, P. Petrou, T. Ben-Hur, O. Abramsky, and S. Slavin, Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch. Neurol. 67, 1187 (2010).
15. S. F. Badylak, Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. Transpl. Immunol. 12, 367 (2004).
16. E. Vorotnikova, D. McIntosh, A. Dewilde, J. Zhang, J. E. Reing, L. Zhang, K. Cordero, K. Bedelbaeva, D. Gourevitch, E. Heber-Katz, S. F. Badylak, and S. J. Braunhut, Extracellular matrix-derived products modulate endothelial and progenitor cell migration and proliferation in vitro and stimulate regenerative healing in vivo. Matrix. Biol. 29, 690 (2010).
17. T. W. Gilbert, T. L. Sellaro, and S. F. Badylak, Decellularization of tissues and organs. Biomaterials 27, 3675 (2006).
18. T. Ahsan and R. M. Nerem, Bioengineered tissues: The science, the technology, and the industry. Orthodontics and Craniofacial Research 8, 134 (2005).
19. B. H. Choi, Y. S. Choi, D. G. Kang, B. J. Kim, Y. H. Song, and H. J. Cha, Cell behavior on extracellular matrix mimic materials based on mussel adhesive protein fused with functional peptides. Biomaterials 31, 8980 (2010).
20. S. W. Choi, Y. Zhang, and Y. Xia, Three-dimensional scaffolds for tissue engineering: The importance of uniformity in pore size and structure. Langmuir: The ACS Journal of Surfaces and Colloids 26, 19001 (2010).
21. V. Carriel, I. Garzon, J. M. Jimenez, A. C. Oliveira, S. Arias-Santiago, A. Campos, M. C. Sanchez-Quevedo, and M. Alaminos, Epithelial and stromal developmental patterns in a novel substitute of the human skin generated with fibrin-agarose biomaterials. Cells, Tissues, Organs. 196, 1 (2012).
22. E. Duval, C. Bauge, R. Andriamanalijaona, H. Benateau, S. Leclercq, S. Dutoit, L. Poulain, P. Galera, and K. Boumediene, Molecular mechanism of hypoxia-induced chondrogenesis and its application in in vivo cartilage tissue engineering. Biomaterials 33, 6042 (2012).
23. C. Wu, Y. Zhou, C. Lin, J. Chang, and Y. Xiao, Strontiumcontaining mesoporous bioactive glass scaffolds with improved osteogenic/cementogenic differentiation of periodontal ligament cells for periodontal tissue engineering. Acta Biomaterialia 8, 3805 (2012).
24. J. Silva-Correia, V. Miranda-Goncalves, A. J. Salgado, N. Sousa, J. M. Oliveira, R. M. Reis, and R. L. Reis, Angiogenic potential of gellan-gum-based hydrogels for application in nucleus pulposus regeneration: in vivo study. Tissue Eng. Part A 18, 1203 (2012).
25. I. Garzon, D. Serrato, O. Roda, M. D. C. Sanchez-Quevedo, M. Gonzales-Jaranay, G. Moreu, R. Nieto-Aguilar, M. Alaminos, and A. Campos, In vitro cytokeratin expression profiling of human oral mucosa substitutes developed by tissue engineering. The International Journal of Artificial Organs 32, 711 (2009).
26. P. Zorlutuna, N. Annabi, G. Camci-Unal, M. Nikkhah, J. M. Cha, J. W. Nichol, A. Manbachi, H. Bae, S. Chen, and A. Khademhosseini, Microfabricated biomaterials for engineering 3D tissues. Adv. Mater. 24, 1782 (2012).
27. M. Lovett, K. Lee, A. Edwards, and D. L. Kaplan, Vascularization strategies for tissue engineering. Tissue Eng. 15B, 353 (2009).
28. C. Correia, W. L. Grayson, M. Park, D. Hutton, B. Zhou, X. E. Guo, L. Niklason, R. A. Sousa, and R. L. Reis, G. Vunjak-Novakovic, In vitro model of vascularized bone: Synergizing vascular development and osteogenesis. PloS One 6, e28352 (2011).
29. Y. Sapir, S. Cohen, G. Friedman, and B. Polyak, The promotion of in vitro vessel-like organization of endothelial cells in magnetically responsive alginate scaffolds. Biomaterials 33, 4100 (2012).
30. S. Koch, C. Yao, G. Grieb, P. Prevel, E. M. Noah, and G. C. Steffens, Enhancing angiogenesis in collagen matrices by covalent incorporation of VEGF. J. Mater. Sci. Mater. Med. 17, 735 (2006).
31. A. H. Zisch, U. Schenk, J. C. Schense, S. E. Sakiyama-Elbert, and J. A. Hubbell, Covalently conjugated VEGF-fibrin matrices for endothelialization. J. Control Release 72, 101 (2001).
32. H. Naderi, M. M. Matin, and A. R. Bahrami, Critical issues in tissue engineering: biomaterials, cell sources, angiogenesis, and drug delivery systems. J. Biomater. Appl. 26, 383 (2011).
33. T. Ziegelhoeffer, B. Fernandez, S. Kostin, M. Heil, R. Voswinckel, A. Helisch, and W. Schaper, Bone marrow-derived cells do not incorporate in the adult growing vasculature. Circ. Res. 94, 230 (2004).
34. M. R. Hoenig, C. Bianchi, and F. W. Sellke, Hypoxia inducible factor-1 alpha, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: a unifying hypothesis. Curr Drug Targets 9, 422 (2008).
35. T. W. Gilbert, A. M. Stewart-Akers, and S. F. Badylak, A quantitative method for evaluating the degradation of biologic scaffold materials. Biomaterials 28, 147 (2007).
36. J. W. Hayami, D. C. Surrao, S. D. Waldman, and B. G. Amsden, Design and characterization of a biodegradable composite scaffold for ligament tissue engineering. Journal of Biomedical Materials Research, Part A 92, 1407 (2010).
37. E. Lavik and R. Langer, Tissue engineering: Current state and perspectives. Appl. Microbiol. Biotechnol. 65, 1 (2004).
38. B. D. Ulery, L. S. Nair, and C. T. Laurencin, Biomedical applications of biodegradable polymers. J. Polym. Sci., Part B: Polym. Phys. 49, 832 (2011).
39. S. H. Song, S. J. Lee, and S. H. Rhee, Synthesis of biodegradable poly(epsilon-caprolactone)-organosiloxane hybrid with carboxylate groups. Journal of Biomedical Materials Research, Part B, Applied Biomaterials 100, 1289 (2012).
40. P. A. Gunatillake and R. Adhikari, Biodegradable synthetic polymers for tissue engineering. European Cells and Materials 5, 1 (2003), Discussion 16.
41. C. Chai and K. W. Leong, Biomaterials approach to expand and direct differentiation of stem cells. Molecular Therapy: The Journal of the American Society of Gene Therapy 15, 467 (2007).
42. L. G. Cima, J. P. Vacanti, C. Vacanti, D. Ingber, D. Mooney, and R. Langer, Tissue engineering by cell transplantation using degradable polymer substrates. Journal of Biomechanical Engineering 113, 143 (1991).
43. H. L. Holtorf, J. A. Jansen, and A. G. Mikos, Ectopic bone formation in rat marrow stromal cell/titanium fiber mesh scaffold constructs: Effect of initial cell phenotype. Biomaterials 26, 6208 (2005).
44. Y. D. Park, N. Tirelli, and J. A. Hubbell, Photopolymerized hyaluronic acid-based hydrogels and interpenetrating networks. Biomaterials 24, 893 (2003).
45. B. K. Mann, A. S. Gobin, A. T. Tsai, R. H. Schmedlen, and J. L. West, Smooth muscle cell growth in photopolymerized hydrogels with cell adhesive and proteolytically degradable domains: Synthetic ECM analogs for tissue engineering. Biomaterials 22, 3045 (2001).
46. J. M. Oliveira, R. A. Sousa, N. Kotobuki, M. Tadokoro, M. Hirose, J. F. Mano, R. L. Reis, and H. Ohgushi, The osteogenic differentiation of rat bone marrow stromal cells cultured with dexamethasone-loaded carboxymethylchitosan/poly(amidoamine) dendrimer nanoparticles. Biomaterials 30, 804 (2009).
47. A. R. Costa-Pinto, R. L. Reis, and N. M. Neves, Scaffolds based bone tissue engineering: The role of chitosan. Tissue Eng. Part B Rev. 17, 331 (2011).
48. S. Young, M. Wong, Y. Tabata, and A. G. Mikos, Gelatin as a delivery vehicle for the controlled release of bioactive molecules. Journal of Controlled Release: Official Journal of the Controlled Release Society 109, 256 (2005).
49. H. Wang, J. Zhou, Z. Liu, and C. Wang, Injectable cardiac tissue engineering for the treatment of myocardial infarction. Journal of Cellular and Molecular Medicine 14, 1044 (2010).
50. M. K. Nguyen and D. S. Lee, Injectable biodegradable hydrogels. Macromolecular Bioscience 10, 563 (2010).
51. C. Shi, Y. Zhu, X. Ran, M. Wang, Y. Su, and T. Cheng, Therapeutic potential of chitosan and its derivatives in regenerative medicine. The Journal of Surgical Research 133, 185 (2006).
52. M. W. Laschke, M. Rucker, G. Jensen, C. Carvalho, R. Mulhaupt, N. C. Gellrich, and M. D. Menger, Incorporation of growth factor containing Matrigel promotes vascularization of porous PLGA scaffolds. Journal of Biomedical Materials Research, Part A 85, 397 (2008).
53. J. M. Melero-Martin, Z. A. Khan, A. Picard, X. Wu, S. Paruchuri, and J. Bischoff, In vivo vasculogenic potential of human bloodderived endothelial progenitor cells. Blood 109, 4761 (2007).
54. J. B. Leach, K. A. Bivens, C. W. Patrick, Jr, and C. E. Schmidt, Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds. Biotechnology and Bioengineering 82, 578 (2003).
55. P. M. Crapo, T. W. Gilbert, and S. F. Badylak, An overview of tissue and whole organ decellularization processes. Biomaterials 32, 3233 (2011).
56. M. Gonzalez-Andrades, J. D. Cardona, A. M. Ionescu, A. Campos, M. D. Perez, and M. Alaminos, Generation of bioengineered corneas with decellularized xenografts and human keratocytes. Invest. Ophthalmol. Vis. Sci. 52, 215 (2011).
57. S. F. Badylak, D. Taylor, and K. Uygun, Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu. Rev. Biomed. Eng. 13, 27 (2011).
58. D. Barkan, J. E. Green, and A. F. Chambers, Extracellular matrix: A gatekeeper in the transition from dormancy to metastatic growth. Eur. J. Cancer 46, 1181 (2010).
59. T. H. Petersen, E. A. Calle, L. Zhao, E. J. Lee, L. Gui, M. B. Raredon, K. Gavrilov, T. Yi, Z. W. Zhuang, C. Breuer, E. Herzog, and L. E. Niklason, Tissue-engineered lungs for in vivo implantation. Science 329, 538 (2010).
60. B. N. Brown, J. E. Valentin, A. M. Stewart-Akers, G. P. McCabe, and S. F. Badylak, Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 30, 1482 (2009).
61. K. A. Daly, S. Liu, V. Agrawal, B. N. Brown, S. A. Johnson, C. J. Medberry, and S. F. Badylak, Damage associated molecular patterns within xenogeneic biologic scaffolds and their effects on host remodeling. Biomaterials 33, 91 (2012).
62. A. B. Daly, J. M. Wallis, Z. D. Borg, R. W. Bonvillain, B. Deng, B. A. Ballif, D. M. Jaworski, G. B. Allen, and D. J. Weiss, Initial binding and recellularization of decellularized mouse lung scaffolds with bone marrow-derived mesenchymal stromal cells. Tissue Eng. Part A 18, 1 (2012).
63. M. T. Conconi, P. De Coppi, R. Di Liddo, S. Vigolo, G. F. Zanon, P. P. Parnigotto, and G. G. Nussdorfer, Tracheal matrices, obtained by a detergent-enzymatic method, support in vitro the adhesion of chondrocytes and tracheal epithelial cells. Transpl. Int. 18, 727 (2005).
64. S. Baiguera, B. D'Innocenzo, and P. Macchiarini, Current status of regenerative replacement of the airway. Expert. Rev. Respir. Med. 5, 487 (2011).
65. F. M. Chen and Y. Jin, Periodontal tissue engineering and regeneration: Current approaches and expanding opportunities. Tissue Eng. Part B Rev. 16, 219 (2010).
66. R. E. Guldberg, Spatiotemporal delivery strategies for promoting musculo-skeletal tissue regeneration. J. Bone Miner. Res. 24, 1507 (2009).
67. R. Langer, Drug delivery and targeting. Nature 392, 5 (1998).
68. F. M. Chen, R. M. Shelton, Y. Jin, and I. L. Chapple, Localized delivery of growth factors for periodontal tissue regeneration: Role, strategies, and perspectives. Med. Res. Rev. 29, 472 (2009).
69. R. R. Chen, E. A. Silva, W. W. Yuen, A. A. Brock, C. Fischbach, A. S. Lin, R. E. Guldberg, and D. J. Mooney, Integrated approach to designing growth factor delivery systems. FASEB J. 14, 3896 (2007).
70. F. M. Andreopoulos and I. Persaud, Delivery of basic fibroblast growth factor (bFGF) from photoresponsive hydrogel scaffolds. Biomaterials 27, 2468 (2006).
71. E. A. Silva and D. J. Mooney, Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. J. Thromb. Haemost. 5, 590 (2007).
72. N. Kikuchi, C. Kitamura, T. Morotomi, Y. Inuyama, H. Ishimatsu, Y. Tabata, T. Nishihara, and M. Terashita, Formation of dentin-like particles in dentin defects above exposed pulp by controlled release of fibroblast growth factor 2 from gelatin hydrogels. J. Endodont. 33, 1198 (2007).
73. M. Ishihara, K. Obara, S. Nakamura, M. Fujita, K. Masuoka, Y. Kanatani, B. Takase, H. Hattori, Y. Morimoto, M. Ishihara, T. Maehara, and M. Kikuchi, Chitosan hydrogel as a drug delivery carrier to control angiogenesis. J. Artif. Organs. 9, 8 (2006).
74. R. Langer and D. A. Tirell, Designing materials for biology and medicine. Nature 428, 487 (2004).
75. K. Y. Lee, M. C. Peters, K. W. Anderson, and D. J. Mooney, Controlled growth factor release from synthetic extracellular matrices. Nature 408, 998 (2000).
76. T. P. Richardson, M. C. Peters, A. B. Ennett, and D. J. Mooney, Polymeric system for dual growth factor delivery. Nat. Biotechnol. 19, 1029 (2001).
77. S. Ponce, G. Orive, R. M. Hernández, A. R. Gascón, J. M. Canals, M. T. Muñoz, and J. L. Pedraz, In vivo evaluation of EPO-secreting cells immobilized in different alginate-PLL microcapsules. J. Control Release 116, 28 (2006).
78. L. Grandoso, S. Ponce, I. Manuel, A. Arrúe, J. A. Ruiz-Ortega, I. Ulibarri, G. Orive, R. M. Hernández, A. Rodríguez, R. Rodríguez-Puertas, M. Zumárraga, G. Linazasoro, J. L. Pedraz, and L. Ugedo, Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats. Int. J. Pharm. 343, 69 (2007).
79. G. Orive, M. De Castro, H. J. Kong, R. M. Hernández, S. Ponce, D. J. Mooney, and J. L. Pedraz, Bioactive cell-hydrogel microcapsules for cell-based drug delivery. J. Control Release 135, 203 (2009).
80. T. Yasuhara and I. Date, Intracerebral transplantation of genetically engineered cells for Parkinson's disease: Toward clinical application. Cell Transplant. 16, 1 (2007).
81. L. C. Yeh, M. L. Adamo, M. S. Olson, and J. C. Lee, Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation. 138, 4181 (1997).
82. L. C. Yeh, M. C. Zavala, and J. C. Lee, Osteogenic protein-1 and interleukin-6 with its soluble receptor synergistically stimulate rat osteoblastic cell differentiation. J. Cell Physiol. 190, 322 (2002).
83. E. Canalis, T. L. McCarthy, and M. Centrella, Effects of plateletderived growth factor on bone formation in vitro. J. Cell Physiol. 140, 530 (1989).
84. R. L. Vonau, M. P. Bostrom, P. Aspenberg, and A. E. Sams, Combination of growth factors inhibits bone ingrowth in the bone harvest chamber. Clin. Orthop. 386, 243 (2001).
85. U. Ripamonti, J. Crooks, J. C. Petit, and D. C. Rueger, Periodontal tissue regeneration by combined applications of recombinant human osteogenic protein-1 and bone morphogenetic protein-2, A pilot study in Chacma baboons (Papio ursinus). Eur. J. Oral. Sci. 109, 241 (2001).
86. L. J. Marden, R. S. Fan, G. F. Pierce, A. H. Reddi, and J. O. Hollinger, Platelet-derived growth factor inhibits bone regeneration induced by osteogenin, a bone morphogenetic protein, in rat craniotomy defects. J. Clin. Invest. 92, 2897 (1993).
87. A. T. Raiche and D. A. Puleo, In vitro effects of combined and sequential delivery of two bone growth factors. Biomaterials 25, 677 (2004).
88. Y. Tabata, Tissue regeneration based on growth factor release. Tissue Eng. 9, S5 (2003).
89. E. Anitua, M. Sánchez, and G. Orive, Potential of endogenous regenerative technology for in situ regenerative medicine. Adv. Drug Deliv. Rev. 62, 741 (2010).
90. E. Anitua, Plasma rich in growth factors: Preliminary results of use in the preparation of future sites for implants. Int. J. Oral. Maxillofac Implants. 14, 529 (1999).
91. M. Sánchez, E. Anitua, J. Azofra, I. Andía, S. Padilla, and I. Mujika, Comparison of surgically repaired Achilles tendon tears using PRGF. Am. J. Sports Med. 35, 245 (2007).
92. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, Estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047 (2004).
93. E. Anitua, J. J. Aguirre, J. Algorta, E. Ayerdi, A. I. Cabezas, G. Orive, and I. Andia, Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J. Biomed. Mater. Res. B Appl. Biomater. 84, 415 (2008).